Literature DB >> 132511

Altered growth hormone release in Huntington's chorea.

H J Keogh, R H Johnson, R N Nanda, W R Sulaiman.   

Abstract

Glucose tolerance tests have been performed on five patients with Huntington's chorea and no difference in response has been observed compared with seven controls. Insulin tolerance tests have been performed on 12 patients with Huntington's chorea and 10 controls. Blood samples were taken at regular intervals for 75 minutes and analysed for blood glucose, insulin, and growth hormone (HGH). There was no difference between the groups in the hypoglycaemia which developed. The patients, however, had an earlier elevation of HGH than the controls. The difference was highly significant (P less than 0.001, P less than 0.02) 30 and 35 minutes after the intravenous injection of insulin. The patients, although awake, ceased to have choreiform movements for at least the last 60 minutes of the insulin tolerance tests. Our observations of HGH release imply that hypothalamic activity is altered in Huntington's chorea. Further observations of HGH release may therefore be of value in its diagnosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132511      PMCID: PMC492262          DOI: 10.1136/jnnp.39.3.244

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Dopamine and basal ganglia diseases.

Authors:  A BARBEAU
Journal:  Arch Neurol       Date:  1961-01

2.  Some observations on Huntington's chorea.

Authors:  A D FORREST
Journal:  J Ment Sci       Date:  1957-07

3.  Control of post-pneumoencephalographic headaches with EC 112; a preliminary review.

Authors:  L B MANN; A B WEBER
Journal:  Bull Los Angel Neuro Soc       Date:  1953-03

4.  A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea.

Authors:  D L McLellan; R J Chalmers; R H Johnson
Journal:  Lancet       Date:  1974-01-26       Impact factor: 79.321

5.  Increased frequency of diabetes mellitus in patients with Huntington's chorea.

Authors:  S Podolsky; N A Leopold; D S Sax
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

6.  Use of L-dopa in the detection of presymptomatic Huntington's chorea.

Authors:  H L Klawans; G W Paulson; S P Ringel; A Barbeau
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

7.  A pharmacologic analysis of Huntington's chorea.

Authors:  H L Klawans
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

8.  Cerebrospinal fluid homovanillic acid in Huntington's chorea.

Authors:  H L Klawans
Journal:  J Neurol Sci       Date:  1971-07       Impact factor: 3.181

9.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

10.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
View more
  13 in total

1.  Predictive tests in Huntington's chorea.

Authors: 
Journal:  Br Med J       Date:  1978-03-04

2.  Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.

Authors:  R J Chalmers; R H Johnson; H J Keogh; R N Nanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

3.  Insulin-induced hypoglycaemia does not abolish chorea.

Authors:  N P Quinn; A E Lang; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

4.  Insulin-induced hypoglycaemia does not abolish chorea.

Authors:  N P Quinn; A E Lang; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

5.  Loss of huntingtin-associated protein 1 impairs insulin secretion from pancreatic β-cells.

Authors:  Austin Cape; Xingxing Chen; Chuan-En Wang; Ashley O'Neill; Yung-Feng Lin; Jun He; Xing-Shun Xu; Hong Yi; He Li; Shihua Li; Xiao-Jiang Li
Journal:  Cell Mol Life Sci       Date:  2011-05-05       Impact factor: 9.261

Review 6.  Metabolism in Huntington's disease: a major contributor to pathology.

Authors:  Akanksha Singh; Namita Agrawal
Journal:  Metab Brain Dis       Date:  2021-10-27       Impact factor: 3.655

7.  Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by Huntingtin-associated Protein 1.

Authors:  Jing-Ying Pan; Shijin Yuan; Tao Yu; Cong-Lin Su; Xiao-Long Liu; Jun He; He Li
Journal:  J Biol Chem       Date:  2016-09-13       Impact factor: 5.157

8.  Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.

Authors:  Mahmoud A Pouladi; Yuanyun Xie; Niels Henning Skotte; Dagmar E Ehrnhoefer; Rona K Graham; Jeong Eun Kim; Nagat Bissada; X William Yang; Paolo Paganetti; Robert M Friedlander; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2010-01-22       Impact factor: 6.150

9.  Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.

Authors:  R Durso; C A Tamminga; S Ruggeri; A Denaro; S Kuo; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-12       Impact factor: 10.154

10.  Studies of hypothalamic function in Huntington's chorea.

Authors:  P J Lavin; I Bone; P Sheridan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.